SCHEMBL7955047

SCHEMBL7955047

c1ccc(-c2noc(-c3ccccc3OC3CC4CCN(C4)C3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 1/20 0.45
SMN1; SMN2 Q16637 9/20 0.44
MAPT P10636 6/20 0.44
TP53 P04637 5/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
NFKB1 P19838 4/20 0.44
NFKB2 Q00653 4/20 0.44
RELA Q04206 4/20 0.44
HSD17B10 Q99714 4/20 0.44
ALDH1A1 P00352 4/20 0.44
MAPK1 P28482 3/20 0.44
KDM4E B2RXH2 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
HPGD P15428 2/20 0.44
TSHR P16473 2/20 0.44
ATM Q13315 1/20 0.44
RAB9A P51151 7/20 0.43
NPC1 O15118 6/20 0.43
NMT1 P30419 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7959021 0.81 MAPT (0.50) GPR55SMN1; SMN2MAPTTP53L3MBTL1
SCHEMBL7947523 0.80 MAPT (0.54) GPR55SMN1; SMN2MAPTTP53L3MBTL1
Dimethylamine SCHEMBL7961529 0.75 NMT1 (0.51) GPR55SMN1; SMN2MAPTTP53L3MBTL1
SCHEMBL7961699 0.69 SMN1; SMN2 (0.81) GPR55SMN1; SMN2MAPTTP53L3MBTL1
SCHEMBL7961528 0.68 SMN1; SMN2 (0.46) GPR55SMN1; SMN2MAPTTP53L3MBTL1
SCHEMBL7947708 0.67 CHRNB4 (0.54) TTRNPSR1
SCHEMBL7957021 0.66 KDM4E (0.58) GPR55SMN1; SMN2TP53L3MBTL1ALDH1A1
SCHEMBL6428833 0.66 SMN1; SMN2 (0.62) GPR55SMN1; SMN2MAPTTP53L3MBTL1
SCHEMBL17474439 0.65 KCNH2 (0.53) MAPTALDH1A1RAB9ANPC1HTT
SCHEMBL7962009 0.65 KDM4E (0.60) GPR55SMN1; SMN2TP53L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277872-B1 ANTIISCHEMIC AGENTS; BRAIN DISORDERS BOEHRINGER INGELHEIM KG (DE) 2001-08-21 US disclosed